Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
If you’re looking for an affordable Windows machine under $500, a blazing fast gaming beast for those intense matches, or a portable 2-in-1 for school or work, you’ve got plenty of great choices right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results